ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 109 filers reported holding ENZO BIOCHEM INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,813,614 | -24.0% | 985,660 | +0.3% | 0.01% | -28.6% |
| Q1 2023 | $2,387,560 | +169712.2% | 982,535 | -0.1% | 0.01% | +55.6% |
| Q4 2022 | $1,406 | -99.9% | 983,285 | +1.3% | 0.01% | -43.8% |
| Q3 2022 | $2,165,000 | +9.2% | 971,010 | +1.4% | 0.02% | +14.3% |
| Q2 2022 | $1,982,000 | -28.2% | 957,485 | +0.7% | 0.01% | -12.5% |
| Q1 2022 | $2,759,000 | -9.2% | 951,235 | +0.5% | 0.02% | -11.1% |
| Q4 2021 | $3,038,000 | -8.9% | 946,285 | +0.5% | 0.02% | -18.2% |
| Q3 2021 | $3,334,000 | +11.2% | 941,760 | -0.5% | 0.02% | +15.8% |
| Q2 2021 | $2,999,000 | +4513.8% | 946,185 | +10074.0% | 0.02% | +1800.0% |
| Q4 2016 | $65,000 | +38.3% | 9,300 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $47,000 | -16.1% | 9,300 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $56,000 | +33.3% | 9,300 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $42,000 | – | 9,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,886,771 | $10,219,000 | 13.54% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $18,323,000 | 6.51% |
| Evermore Global Advisors, LLC | 1,730,607 | $6,126,000 | 5.39% |
| VIEX Capital Advisors, LLC | 1,510,401 | $5,347,000 | 3.24% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $90,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $886,000 | 0.05% |
| CORRADO ADVISORS, LLC | 19,366 | $69,000 | 0.04% |
| Cutter & CO Brokerage, Inc. | 27,827 | $99,000 | 0.02% |
| Ergoteles LLC | 177,048 | $627,000 | 0.02% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 941,760 | $3,334,000 | 0.02% |